New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Localizing BRCA gene mutations to better treat ovarian cancer

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n
Oncology December 20,2023
Localizing BRCA gene mutations to better treat ovarian cancer

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n
Oncology December 20,2023
Endoscopic approaches feasible in surgery for sinonasal cancer

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,
Oncology December 20,2023
Endoscopic approaches feasible in surgery for sinonasal cancer

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,
Oncology December 20,2023
Timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

Timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

byUniversity of California, Los AngelesUnadjusted Kaplan-Meier and cumulative incidence curves evaluating the associations between concurrent/adjuvant versus neoadjuvant/concurrent ADT sequencin
Oncology December 20,2023
Timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

Timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

byUniversity of California, Los AngelesUnadjusted Kaplan-Meier and cumulative incidence curves evaluating the associations between concurrent/adjuvant versus neoadjuvant/concurrent ADT sequencin
Oncology December 20,2023
High BMI may improve cancer survival

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d
Oncology December 20,2023
High BMI may improve cancer survival

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d
Oncology December 20,2023
Surgery may add months or years of survival for adults with rare and deadly brain cancers

Surgery may add months or years of survival for adults with rare and deadly brain cancers

by Amy Mone,Johns Hopkins UniversityCredit: Alicia Ortega, MSFor adult patients with brainstem high-grade gliomas—one of the rarest and deadliest forms of brain cancer—surgically removing the en
Oncology December 20,2023
Surgery may add months or years of survival for adults with rare and deadly brain cancers

Surgery may add months or years of survival for adults with rare and deadly brain cancers

by Amy Mone,Johns Hopkins UniversityCredit: Alicia Ortega, MSFor adult patients with brainstem high-grade gliomas—one of the rarest and deadliest forms of brain cancer—surgically removing the en
Oncology December 20,2023
Individualized physical therapy reduces incontinence, pain in men after prostate surgery

Individualized physical therapy reduces incontinence, pain in men after prostate surgery

byUT Southwestern Medical CenterDr. Kelly Scott. Credit: UT Southwestern Medical CenterFor decades, therapy to strengthen pelvic muscles has been the standard treatment for men dealing with urin
Nephrology & Urology December 20,2023
Individualized physical therapy reduces incontinence, pain in men after prostate surgery

Individualized physical therapy reduces incontinence, pain in men after prostate surgery

byUT Southwestern Medical CenterDr. Kelly Scott. Credit: UT Southwestern Medical CenterFor decades, therapy to strengthen pelvic muscles has been the standard treatment for men dealing with urin
Nephrology & Urology December 20,2023
Quantitative pathologic analysis may help predict prognosis in colorectal cancer

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.
Oncology December 20,2023
Quantitative pathologic analysis may help predict prognosis in colorectal cancer

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.
Oncology December 20,2023
Research identifies new route for tackling drug resistance in skin cancer cells

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c
Oncology December 20,2023
Research identifies new route for tackling drug resistance in skin cancer cells

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c
Oncology December 20,2023
Top medical groups, hospitals urge better access to lung cancer screening

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50
Oncology December 20,2023
Top medical groups, hospitals urge better access to lung cancer screening

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50
Oncology December 20,2023
Genetic study provides most comprehensive map of risk to date of breast cancer risk

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's
Oncology December 20,2023
Genetic study provides most comprehensive map of risk to date of breast cancer risk

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's
Oncology December 20,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com